Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyStart Health vs Oxford's Medical Weight Loss (The Calibrate Clinic)

MyStart Health
Graded #168

Higher grade

vs+12.099999999999994

The verdict

MyStart Health takes it — 67.1/100 to 55/100.

MyStart Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyStart Health offers all-inclusive compounded semaglutide and tirzepatide at $299/month with a price-lock guarantee, same-day physician consultations, and 24/7 care team access.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyStart Health +3
48
45
Dose & formulationMyStart Health +43
83
40
Clinical oversightMyStart Health +12
84
72
Labs & monitoringMyStart Health +5
66
61
FulfillmentMyStart Health +13
78
65
Contract termsOxford's Medical Weight Loss (The Calibrate Clinic) +24
31
55
MyStart Health · left barOxford's Medical Weight Loss (The Calibrate Clinic) · right bar

The numbers

MetricMyStart HealthOxford's Medical Weight Loss (The Calibrate Clinic)
WeighScore67.1/10055/100
GradeCC
Scorecard rank#168#449
Semaglutide$299/mo (all doses, compounded)Not disclosed
Tirzepatide$299/mo (all doses, compounded)Not disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
MyStart Health

Graded #168 · C

Strengths

  • Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
  • Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 care team access with unlimited clinician messaging included
  • LegitScript certified
  • Clear Section 503A compounding disclosure on every landing page

Where it loses points

  • Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
  • Very new company (incorporated May 2024) with a limited track record
  • Pharmacy partners not named, so 503A compliance can't be independently verified

Strengths

  • Both semaglutide and tirzepatide available
  • No monthly doctor fees and free, no-obligation consultation; free shipping to your door

Where it loses points

  • Only a '$149 starting' figure is advertised (drug/dose unspecified); full GLP-1 pricing stays quote-gated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard